Serami Murakami
Hiroshima, 7398551, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Prime editing enables isogenic modeling of PNPLA3-I148M-associated lipotoxicity in hepatocytes.
Journal: Molecular therapy. Nucleic acids
Published: January 07, 2026
The Efficacy and Safety of Atezolizumab Plus Bevacizumab after Durvalumab Plus Tremelimumab for the Treatment of Hepatocellular Carcinoma.
Journal: Internal medicine (Tokyo, Japan)
Published: September 03, 2025
Prediction of Hepatocellular Carcinoma After Hepatitis C Virus Sustained Virologic Response Using a Random Survival Forest Model.
Journal: JCO clinical cancer informatics
Published: December 18, 2024
Time trend of outcomes according to systemic therapy for patients with unresectable hepatocellular carcinoma: A single-institution study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 07, 2024
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 09, 2024
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Journal: Cancers
Published: March 17, 2024
Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure.
Journal: Hepatology international
Published: May 27, 2023
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
Journal: Journal of gastroenterology and hepatology
Published: March 26, 2023
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
Journal: BMC gastroenterology
Published: November 29, 2022
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure.
Journal: Hepatology international
Published: November 18, 2022
Last Updated: 09/26/2026